IL92759A - Pharmaceutical preparations containing a history of 1,2,3,4-tetrahydroacridine - Google Patents

Pharmaceutical preparations containing a history of 1,2,3,4-tetrahydroacridine

Info

Publication number
IL92759A
IL92759A IL9275989A IL9275989A IL92759A IL 92759 A IL92759 A IL 92759A IL 9275989 A IL9275989 A IL 9275989A IL 9275989 A IL9275989 A IL 9275989A IL 92759 A IL92759 A IL 92759A
Authority
IL
Israel
Prior art keywords
composition according
tetrahydroacridine
pharmaceutical composition
active ingredient
amino
Prior art date
Application number
IL9275989A
Other languages
English (en)
Hebrew (he)
Other versions
IL92759A0 (en
Original Assignee
S C R Newpharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S C R Newpharm filed Critical S C R Newpharm
Publication of IL92759A0 publication Critical patent/IL92759A0/xx
Publication of IL92759A publication Critical patent/IL92759A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08—Nitrogen atoms
    • C07D219/10—Nitrogen atoms attached in position 9

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL9275989A 1988-12-19 1989-12-18 Pharmaceutical preparations containing a history of 1,2,3,4-tetrahydroacridine IL92759A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR888816749A FR2640508B1 (fr) 1988-12-19 1988-12-19 Nouvelles compositions et nouveaux produits pharmaceutiques assurant la regeneration de leucocytes et leur emploi pour le traitement du syndrome immuno-deficitaire

Publications (2)

Publication Number Publication Date
IL92759A0 IL92759A0 (en) 1990-09-17
IL92759A true IL92759A (en) 1994-06-24

Family

ID=9373109

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9275989A IL92759A (en) 1988-12-19 1989-12-18 Pharmaceutical preparations containing a history of 1,2,3,4-tetrahydroacridine

Country Status (19)

Country Link
EP (1) EP0375471B1 (ja)
JP (1) JPH02258722A (ja)
KR (1) KR900009075A (ja)
AP (1) AP125A (ja)
AT (1) ATE136463T1 (ja)
AU (2) AU4686189A (ja)
CA (1) CA2005925C (ja)
DE (1) DE68926222D1 (ja)
DK (1) DK646489A (ja)
FR (1) FR2640508B1 (ja)
HU (1) HU213510B (ja)
IL (1) IL92759A (ja)
MA (1) MA21964A1 (ja)
MY (1) MY106032A (ja)
NZ (1) NZ231854A (ja)
OA (1) OA09250A (ja)
PT (1) PT92620B (ja)
TN (1) TNSN89135A1 (ja)
ZA (1) ZA899733B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5155226A (en) * 1991-02-19 1992-10-13 Hoechst-Roussel Pharmaceuticals Incorporated Method for the preparation of 9-amino-1,2,3,4-tetrahydroacridine
EP0509401A1 (en) * 1991-04-19 1992-10-21 Hoechst-Roussel Pharmaceuticals Incorporated Use of 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds for the treatment of aids
RU2036198C1 (ru) * 1993-04-01 1995-05-27 Товарищество с ограниченной ответственностью "Полисан" N-МЕТИЛ-N-( α,D -ГЛЮКОПИРАНОЗИЛ) АММОНИЯ-2-(АКРИДОН-9-ОН-10-ИЛ)АЦЕТАТ(ЦИКЛОФЕРОН), ОБЛАДАЮЩИЙ ИНТЕРФЕРОНОГЕННОЙ, ПРОТИВОВИРУСНОЙ, В ТОМ ЧИСЛЕ АНТИВИЧ, АНТИПАРАЗИТАРНОЙ, АНТИПРОМОТОРНОЙ И РАДИОПРОТЕКТИВНОЙ АКТИВНОСТЬЮ

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4916122A (en) * 1987-01-28 1990-04-10 University Of Georgia Research Foundation, Inc. 3'-Azido-2',3'-dideoxyuridine anti-retroviral composition
EP0332626A1 (en) * 1986-11-21 1989-09-20 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Compositions for treating viral infections in humans
IL86009A (en) * 1987-04-10 1991-09-16 Us Health Liposome-encapsulated phosphorylated nucleosides for treatment of retroviral diseases
US5013741A (en) * 1987-09-08 1991-05-07 Hoechst-Roussel Pharmaceuticals Incorporated N-[substituted alkylidene]-1,2,3,4-tetrahydro-9-acridinamines useful for enhancing the cholinergic function in a mammal
US4985430A (en) * 1987-12-03 1991-01-15 Mitsubishi Kasei Corporation 9-acylamino-tetrahydroacridine derivatives and memory enhancing agent containing said derivative as active ingredient
CH678275A5 (ja) * 1989-05-25 1991-08-30 Debiopharm Sa
US4999358A (en) * 1989-06-26 1991-03-12 Hoechst-Roussel Pharmaceuticals Inc. (1,2,3,4-tetrahydro-9-acridinimino)cyclohexane carboxylic acid and related compounds
US4999430A (en) * 1989-07-31 1991-03-12 Warner-Lambert Company Derivatives of 1,2,3,4-tetrahydro-9-acrisinamine

Also Published As

Publication number Publication date
AU3980693A (en) 1993-08-19
ZA899733B (en) 1991-04-24
JPH02258722A (ja) 1990-10-19
AU666725B2 (en) 1996-02-22
FR2640508A1 (fr) 1990-06-22
MA21964A1 (fr) 1991-07-01
DE68926222D1 (de) 1996-05-15
DK646489A (da) 1990-06-20
HU896683D0 (en) 1990-02-28
AP8900157A0 (en) 1990-01-31
IL92759A0 (en) 1990-09-17
DK646489D0 (da) 1989-12-19
CA2005925A1 (fr) 1990-06-19
FR2640508B1 (fr) 1994-07-01
PT92620B (pt) 1995-09-12
KR900009075A (ko) 1990-07-02
MY106032A (en) 1995-02-28
ATE136463T1 (de) 1996-04-15
EP0375471B1 (fr) 1996-04-10
EP0375471A3 (fr) 1992-07-08
EP0375471A2 (fr) 1990-06-27
AU4686189A (en) 1990-06-21
CA2005925C (fr) 2002-03-26
TNSN89135A1 (fr) 1991-02-04
HU213510B (en) 1997-07-28
PT92620A (pt) 1990-06-29
NZ231854A (en) 1993-01-27
AP125A (en) 1991-03-19
OA09250A (fr) 1992-06-30

Similar Documents

Publication Publication Date Title
SU1299508A3 (ru) Способ получени производных 8-хлор-1,5-бензтиазепина или их фармацевтически приемлемых кислотно-аддитивных солей
US6127384A (en) Compounds, compositions and methods for treatment of hepatitis C
WO1995017876A2 (en) 2,4-disulphophenyl butylnitrone, its salts, and their use as pharmaceutical spintraps
US4452800A (en) Salts of 3(n-butyl)-4-hydroxy-1-phenyl-1,8-naphthyridine-2(1H)-one and their use in treating chronic obstructive lung diseases
US4778798A (en) Pharmaceutical compositions having vasodilating and antianoxic activities
IL92759A (en) Pharmaceutical preparations containing a history of 1,2,3,4-tetrahydroacridine
US6734192B1 (en) Treatment of viral infections
US6399658B1 (en) Composition containing ascorbic acid
CS255891B2 (en) Process for preparing new derivatives of amidine
CA1291752C (en) Furanuronic acid derivatives, process for their production and their use
US5962480A (en) Drug for ameliorating brain diseases
JPH11500130A (ja) 抗ウイルス性トリアザ化合物
EP1210116B1 (en) Pharmaceutical combination for the treatment of viral infections containing a calcium channel blocker and a quinoline
Tan et al. Phase II study of 4′-(9-acridinylamino) methanesulfon-m-anisidide (NSC 249992) in children with acute leukemia and lymphoma
EP0617959A1 (en) Pharmaceutical for the treatment of skin disorders
US3979511A (en) Inhibitors of reverse transcriptase enzymes
CZ290550B6 (cs) Krystalický (+) L-hydrogenvinan 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridinu, způsob jeho přípravy, farmaceutický prostředek jej obsahující a jeho pouľití
KR930000049B1 (ko) 세트랄린을 사용한 화학약품 의존성의 치료방법
JPS61257925A (ja) 抗ウイルスヌクレオシド
US4766126A (en) Process for treatment of nephritis with imidazoquinazolines
EP0697215A1 (en) Digestive symptom ameliorant
US5278167A (en) 6-pyridyl substituted pyrimidine derivatives
KR100194825B1 (ko) 말초 순환 개선제
CA2180732A1 (en) Anti-hiv drugs
KR850000783B1 (ko) 모노하이드레이티드 이소프탈산 피콜릴아미드의 제조방법

Legal Events

Date Code Title Description
RH Patent void
MM9K Patent not in force due to non-payment of renewal fees